After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists
After more than 50 years, the federal government is lifting a roadblock to cannabis research that scientists and advocates say has hindered rigorous studies of the plant and possible drug development.
Since 1968, U.S. researchers have been allowed to use cannabis from only one domestic source: a facility based at the University of Mississippi, through a contract with the National Institute on Drug Abuse (NIDA).
That changed earlier this month, when the Drug Enforcement Administration announced it’s in the process of registering several additional American companies to produce cannabis for medical and scientific purposes.
Stories you may be interested in
How Medical Marijuana Affects Men vs. Women
As expected, men and women differ in a multitude of ways, from genetic makeup and hormonal behavior to how we process information and emotionally respond. The differences in our makeup are the exact reason why any medical treatment, including medical marijuana, will have a diverse impact on men vs. women. Let’s take a closer look…
Read More 
Arfinn Med March Updates
We are very happy to announce the release of several new functions within the Arfinn Med Platform. Those include: * Text message updates from patients regarding their treatments * Templating for exam notes * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More 
Alternative Mississippi medical marijuana program barely wins approval from Senate
JACKSON • Legislation that would create a new medical marijuana program in Mississippi if the voter-approved Initiative 65 is overturned in court cleared the state Senate on the second try last week early on Friday morning. Senate Bill 2765, the Mississippi Medical Cannabis Act, failed by a single vote Thursday evening. But six hours later, after…
Read More 
Florida medical marijuana dispensary now sells the state’s first cannabis tablet
Even though Florida residents can finally smoke medical marijuana, one of the state’s largest cannabis companies is now offering it in tablet form. The company Curaleaf released the state’s first cannabis tablet on Sunday. The company’s two Orlando locations, at 775 N Semoran Blvd. and 12402 S Orange Blossom Trail, sell the mint-flavored tablets for $35 for a 30-quantity, child-resistant package. Read…
Read More 
Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says
Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More 
Unstructured EHR data more useful for predictive analytics, study shows
A new report in the Journal of the American Medical Informatics Association has shown that real-world data contained in unstructured narratives has big predictive value when it comes to clinical research. WHY IT MATTERSWhile structured clinical notes in the electronic health record have obvious value, the research in JAMIA suggests that real-world data captured in unstructured notes…
Read More